ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 359239 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 359239; 2) Community: the network communities that were significantly associated with the response to NSC 359239; 3) Molecule: the relationships between components within communities and NSC 359239; 4) MDR: the compounds that were significantly associated with the NSC 359239.

NSC Compound Enrichment Correlation
NSC 725202 Null 0.0114553853234977 -0.033114005
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.0114553853234977 -0.0080431771
NSC 728512 1-Allyl-2-[4-chloro-5-(4-chlorophenylcarbamoyl)-2-methylthio benzenesulfonyl]-3-(5-nitro-2-furfulienimino)guanidine 0.0114553853234977 0.080776093
NSC 737518 Indenoisoquinoline derivative 0.0114553853234977 0.058638503
NSC 757098 Melphalan (USAN) 0.0114553853234977 0.011730998
NSC 118218 2-Fluoro Ara A 0.0126882509540132 -0.19832456
NSC 144153 Datiscoside 0.0126882509540132 0.37048101
NSC 149501 Bleomycinamide, N(1)-[3-[(4-aminobutyl)amino]propyl]-, sulfate (salt) 0.0126882509540132 -0.074766071
NSC 34475 Androst-5-en-16.beta.-ol, 3.beta.-methoxy- (8CI) 0.0126882509540132 0.12537763
NSC 50273 Pyridine, 3-[[4-[bis(2-chloroethyl)amino]-2-methylbenzylidene]amino]- 0.0126882509540134 0.012121133
Total:74  Current:23    [First] [Prev] [Next] [Last]